Lg Display Co., Ltd.

Mogam Institute for Biomedical Research

Yungjin Pharm Co., Ltd.

Huen Co., Ltd.

Curome Biosciences Co., Ltd.

Mi Jung Lee

Seung Hoon Lee

Tae Hwan Kwak

Whee Seong Lee

Bo Jung Kim

Jae Hyun Park

Soo Young Yoon

You-Hui Lee

Kyu Dae Lee

Tae Cheul Roh

Dong-Sik Kim

Juhn Suk Yoo

Yong Chul Kim

Hyung-Kwon Lim

Jong Moo Kim

Young Seoub Park

Jae Chan Park

Se Jong Yoo

Kisu Kim

Ki Joon Cho

Shin A Jang

Ae Rin Yoon

Hye-Ji Choi

Jong Hyun Han

Sumin Lee

Heechun Kwak

Junhong Jeong

SungHo Hwang

Gil-Jung Kim

Mi Young Oh

The present invention relates to a novel antibody library and an antibody-screening method using same. Having a human sequence-derived specific VH or VL scaffold, the antibody library according to the present invention exhibits high thermodynamic stability and enjoys the advantages of allowing high soluble expression as well as reversible folding. In addition, the antibody according to the present invention includes a variety of rationally controlled CDRs so as to exhibit high specificity and high affinity to all antigens and thus can be advantageously used for selecting an adequate candidate antibody against a target antigen.

Antibody library and antibody screening method using same

Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein Rto R,and Xto Xare the same as defined in claim

1,2-naphthoquinone based derivative and method of preparing the same

Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same:

The present invention relates to an antibody that binds specifically to a tissue factor pathway inhibitor (TFPI), a nucleic acid encoding the antibody, a vector comprising the nucleic acid, a host cell transformed with the vector, a method for producing the antibody, and a pharmaceutical composition for treating hemophilia, which comprises the antibody as an active ingredient. The antibody of the present invention, which binds specifically to TFPI, can activate the extrinsic pathway of blood coagulation by inhibiting TFPI. Thus, the antibody of the present invention can be effectively used for the treatment of antibody-induced hemophilia patients and for the prevention of blood coagulation disease in hemophilia-A or hemophilia-B patients.

Antibody binding to TFPI and composition comprising the same

Provided are a touch panel, a method of manufacturing the same, and a touch panel integrated organic light emitting display device. The touch panel includes a substrate, a plurality of connection electrodes, an over-coating layer, a first line electrode, a second line electrode, a plurality of first segment electrodes, and a plurality of second segment electrodes. The plurality of connection electrodes is disposed on the substrate to be separated from each other. The over-coating layer includes a plurality of contact holes exposing a part of each connection electrode. The second line electrode is connected with the connection electrode through the contact hole of the over-coating layer without disconnection.

Touch panel, method of manufacturing the same and touch panel integrated organic light emitting display device

An organic light emitting display device is disclosed. The organic light emitting display device includes: an organic light emitting display panel defined into a display area for displaying an image and a non-display area surrounding the display area; a chip-on-film loaded with a driver IC chip, which is configured to drive the organic light emitting display panel, and attached to a pad portion which is formed on the non-display area of the organic light emitting display panel; and a printed circuit board configured to apply signals to the driver IC chip and attached to one edge of the chip-on-film, wherein the organic light emitting display panel includes a dummy pad portion which is formed on the non-display area in the same configuration as the pad portion and in opposition to the pad portion.

Organic light emitting display device and reworking method thereof

Growing community of inventors

Yongin-si, South Korea

Mi Jung Lee